Clinical Trials Directory

Trials / Completed

CompletedNCT01154400

Hydrolyzed Casein and Whey Protein Supplementation and the Addition of Leucine to Induce Protein Anabolism in Malnourished COPD Patients

Grant Title: Eicosapentaenoic Acid and Protein Modulation to Induce Anabolism in COPD

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
12 (actual)
Sponsor
Texas A&M University · Academic / Other
Sex
All
Age
45 Years
Healthy volunteers
Not accepted

Summary

The aim of this study is the first aim of a NIH project that consists of 3 aims. The first aim examines the acute effects of two high-quality milk proteins (casein vs. whey) on whole-body and muscle protein metabolism in COPD patients with severe loss of muscle mass and the effects of adding leucine. The principal endpoints will be the extent of stimulation of net whole body protein synthesis as this is the principal mechanism by which either amino acid or protein intake causes muscle anabolism. After determining the optimal nutritional formulation based on the first aim we will continue to work on the second and third aim where fish oil supplementation will be part of the nutritional intervention as well.

Detailed description

Cachectic COPD patients are characterized by a decreased muscle protein synthesis and an elevated myofibrillar protein breakdown. A substantial number of these patients, characterized by an enhanced systemic inflammatory response, fails to respond to nutritional therapy, which is of clinical relevance as weight gain to nutritional therapy is a significant, independent predictor of mortality in COPD. In the present study, the acute protein anabolic effect of two high-quality milk protein supplements in COPD will be examined by comparing a hydrolyzed casein and whey protein meal. We make use of hydrolyzed proteins to correct for absorption differences. Furthermore the effects of these milk proteins with or without enrichment of leucine will be investigated. Variables of interest are: net whole body protein synthesis; whole body protein synthesis and breakdown rate; whole body myofibrillar protein breakdown rate; whole body collagen breakdown; kinetics of insulin; glucose; amino acid levels. It is the investigators hypothesis that a nutritional supplement containing casein protein and high levels of leucine will target the metabolic alterations of these cachectic COPD patients and will specifically stimulate protein anabolism. The knowledge gained from this study will benefit our insight in terms of promotion of protein anabolism in COPD patients. The long-term goal is to reformulate nutritional composition in accord with the effects of COPD on protein metabolism in order to ameliorate or even prevent progressive muscle wasting in these subjects, and improve their quality of life and survival rates.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTCasein protein hydrolysates15 g casein protein hydrolysates + 15 g maltodextrin
DIETARY_SUPPLEMENTWhey protein hydrolysates15 g whey protein isolate + 15 g maltodextrin
DIETARY_SUPPLEMENTCasein protein hydrolysates + LEU15 g casein protein hydrolysate + 2.1 g LEU (40% of EAA content) + 15 g maltodextrin
DIETARY_SUPPLEMENTWhey protein hydrolysates + LEU15 g whey protein isolate + 1.5 g LEU (40% of EAA content) + 15 g maltodextrion

Timeline

Start date
2009-05-01
Primary completion
2011-07-01
Completion
2011-07-01
First posted
2010-06-30
Last updated
2012-10-15

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT01154400. Inclusion in this directory is not an endorsement.